Related Experiment Videos
Changing patterns in percutaneous transluminal coronary angioplasty
E M Tuzcu1, C Simpfendorfer, K Dorosti
1Department of Cardiology, Cleveland Clinic Foundation, OH 44195.
American Heart Journal
|June 1, 1989
Summary
Technological advancements in percutaneous transluminal coronary angioplasty (PTCA) significantly improved success rates and reduced complications. Evolving catheter technology led to better outcomes for patients with severe coronary artery disease.
Area of Science:
- Cardiovascular Medicine
- Medical Technology
- Interventional Cardiology
Background:
- Percutaneous transluminal coronary angioplasty (PTCA) is a key intervention for coronary artery disease.
- Technological evolution in PTCA devices and techniques is ongoing.
- Assessing the impact of these advancements on patient outcomes is crucial.
Purpose of the Study:
- To evaluate the effect of evolving PTCA technology on patient outcomes.
- To compare results across different eras defined by catheter technology.
- To analyze trends in success rates and complications over time.
Main Methods:
- Retrospective analysis of 2677 patients undergoing PTCA.
- Categorization into three periods based on catheter technology: fixed-wire, steerable, and low-profile systems.
- Comparison of patient demographics, lesion characteristics, procedural success, and complication rates across periods.
Main Results:
- Patient age and severity of angina increased across periods.
- Primary success rate improved significantly from 73% to 94% with technological advancements.
- Incidence of emergency bypass surgery, myocardial infarction, and mortality showed a decreasing trend, despite increasing patient acuity.
Conclusions:
- Technological evolution in PTCA, including steerable and low-profile catheters, has markedly improved procedural success.
- Advancements in technology and operator experience contribute to reduced major complications and better patient outcomes.
- Ongoing innovation in PTCA is vital for managing complex coronary artery disease.